Secretases as targets for the treatment of Alzheimer's disease: the prospects

This publication has 45 references indexed in Scilit:

• Reduction of amyloid load and cerebral damage in transgenic mouse model of Alzheimer's disease by treatment with a β‐sheet breaker peptide
  The FASEB Journal, 2002
• Axonal Transport, Tau Protein, and Neurodegeneration in Alzheimer's Disease
  NeuroMolecular Medicine, 2002
• Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
  Nature, 1999
• Translating cell biology into therapeutic advances in Alzheimer's disease
  Nature, 1999
• Constitutive and regulated α-secretase cleavage of Alzheimer’s amyloid precursor protein by a disintegrin metalloprotease
  Proceedings of the National Academy of Sciences, 1999
• Metalloprotease-Disintegrin MDC9: Intracellular Maturation and Catalytic Activity
  Journal of Biological Chemistry, 1999
• Memory-enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic mice
  Proceedings of the National Academy of Sciences, 1998
• Evidence That Tumor Necrosis Factor α Converting Enzyme Is Involved in Regulated α-Secretase Cleavage of the Alzheimer Amyloid Protein Precursor
  Journal of Biological Chemistry, 1998
• Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
  Physiological Reviews, 1997
• Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
  Biochemical and Biophysical Research Communications, 1984